Clinical trial · Observational
Predicting Metastatic Oral Squamous Cell Carcinomas With Molecular Biomarkers Using Machine Learning
NCT04543266CI-TRIAL-00047118unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Application Management Team: PI - Siu Wai Choi; email - htswchoi@hku.hk Delegates - Chui Shan Chu; email: sunshine.c@connect.hku.hk FollowUpUsers - Chui Shan Chu; email:sunshine.c@connect.hku.hk
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Oral Squamous Cell Carcinoma | Oral Cavity Squamous Cell Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Surgery | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Patients with Progressive Disease
- description
- Patients with metastasis and/or recurrent OSCC were considered as a group of subjects with progressive disease
- interventionNames
- Procedure: Surgery
- label
- Patients without Progressive Disease
- description
- Patients without metastasis and/or recurrent OSCC were considered as a group of subjects without progressive disease
- interventionNames
- Procedure: Surgery
Primary outcomes (1)
- measure
- The primary outcomes of the study are metastasis and recurrent disease
- timeFrame
- Baseline of OSCC
- description
- These outcomes will be entered as the dependent variables into the machine learning model
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * patients with oral squamous carcinoma * received surgery from 1st October 2000 to 1st October 2019 Exclusion Criteria: N/A
References
Publications (0)
Data not yet available
No reference posted for this study.